Michael Demurjian's Email & Phone Number

💼 Past Experience

Michael Demurjian has been in the Pharmaceuticals Industry for over twenty years, most recently as the CEO of Aspargo Laboratories, Inc. where he led the company's clinical development and regulatory activities. He has been in the business for five years, and previous to this, he was the President and CEO of Luminant Biosciences LLC, a company focused on advancing an innovative cancer therapy through clinical development. Luminant Biosciences LLC was recently acquired by Tyme Inc., a U.S. based publically traded pharmaceutical company. Michael Demurjian is also currently President and CEO of Aspargo Laboratories Inc. and has led the company's clinical development and regulatory activities since its inception.

🎓 Education

Michael Demurjian holds a B.A economics degree from New York University where he completed his studies in 1982. He then continued his education by taking a course in business/managerial economics at New York University from 1988-1992. This course taught him about the business world, its challenges, and how to apply these knowledge to his business career. After completing his coursework at New York University, Michael Demurjian worked as a business analyst for a consulting company from 1992-1996. After six months of work, he left this job to pursue a career in education.Michael Demurjian's education hasEdited him into a career in education. After leaving his job as a business analyst, he pursued a career in education by taking a course in business/managerial economics at New York University. This course taught him about the business world, its challenges, and how to apply these knowledge to his business career. Michael Demurjian has held a career in education since 1996 and has since provided instruction to students of all ages,types of businesses, and economic subjects. He has a registered education Specialist in Education with the Connecticut Board of Education.Since leaving his job as a business analyst, Michael Demurjian has pursued a career in education by taking a course in business/managerial economics at New York University. This course taught him about the business world, its challenges, and how to apply these knowledge to his business career. In 1996, Michael Demurjian was appointed a registered education Specialist with the Connecticut Board of Education, which gave him the opportunity to provide instruction to students of all ages,types of businesses, and economic subjects. He offers instruction in all areas of education, including education for adults, special education, and TEFL/TESOL. Michael Demurjian is known for his passion for providing instruction to students who need it and his dedication to providing quality education. He is an asset to any business,school, or organization and I believe he will continue to provide high-quality education to students for many years to come.

💡 Technical & Interpersonal Skills

Michael Demurjian is an experienced CEO, co-founder, and product lead with over five years of experience in the technology, foodservice, and medical industry. He is also an experienced negotiator and has successfully negotiated acquisitions for his companies. Demurjian is also the founder and CEO of Aspargo Laboratories, Inc., which he started in 2001. Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company focused on developing an oral spray formulation of sildenafil, the active ingredient in Viagra®, in the United States. Aspargo was the exclusive U.S. licensee of the U.S. patent rights covering Sildenafil Oral Spray until it acquisition by GE Aerospace in 2013.Demurjian obtained his undergraduate degree in Business Administration from Monmouth University in 2006. He then proceeded to receive hisJD from New York University in 2009. After receiving his JD, he worked as a legal assistant in New Jersey until he joined the business team at Luminant Biosciences LLC in 2010. He then worked at KITCHEN CONCEPTS LLC from 2007-2010 as the co-founder and co-chief executive officer. From 2007-2010, he was also the founder and CEO of Aspargo Laboratories Inc. Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company focused on developing an oral spray formulation of sildenafil, the active ingredient in Viagra®, in the United States. Aspargo was the exclusive U.S. licensee of the U.S. patent rights covering Sildenafil Oral Spray until it acquisition by GE Aerospace in 2013.The company has multiple products in development, including a spray to be used to treat conditions such as menopausal symptoms, erectile dysfunction, and atherosclerosis. The company is also working on a novel drug that uses the metabolic pathway to attack cancer.In 2001, Demurjian started Aspargo Laboratories, Inc., which he continues to lead. Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company focused on developing an oral spray formulation of sildenafil, the active ingredient in Viagra®, in the United States. Aspargo was the exclusive U.S. licensee of the U.S. patent rights covering Sildenafil Oral Spray until it acquisition by GE Aerospace in 2013.Since its acquisition by GE Aerospace in 2013, Aspargo has increased its production and markets sildenafil oral spray to the U.S. market through its Aspargo Oral Spray subsidiary. The company has also created a new production platform for its orally delivered sildenafil and is in the process of launching a new product.